Pathios brings together a team of experienced scientific leaders and drug discovery professionals to deliver on the therapeutic promise of targeting the innate immune system in cancer. Pathios also benefits from being part of the M:M Bio (Molecule 2 Medicine) ecosystem which is focused on drug discovery company ideation, creation, incubation, and growth. M:M Bio provides organisations like Pathios with operational and R&D support to help them achieve scientific, clinical & commercial success. For more information see www.molecule2medicine.com.
